ATNM

Actinium Pharmaceuticals Inc

Jun 18 • 11:22AM ET

1.03

+0.01 1.16 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: ATOS GRCE INMB LTRN OTLK QNTM RNXT VERU XLO TLPH

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.75	Insider Own	0.60%	Shs Outstand	31.37M	Perf Week	-0.79%
Market Cap	32.37M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	0.00%	Shs Float	31.19M	Perf Month	-10.28%
Enterprise Value	-8.24M	PEG	-	EPS next Q	-0.22	Inst Own	16.90%	Short Float	3.47%	Perf Quarter	-5.34%
Income	-23.47M	P/S	359.67	EPS this Y	22.32%	Inst Trans	-0.93%	Short Ratio	5.90	Perf Half Y	-32.12%
Sales	0.09M	P/B	14.05	EPS next Y	6.30%	ROA	-41.15%	Short Interest	1.08M	Perf YTD	-24.13%
Book/sh	0.07	P/C	0.77	EPS next 5Y	23.57%	ROE	-167.66%	52W High	1.89 -45.41%	Perf Year	-29.33%
Cash/sh	1.34	P/FCF	-	EPS past 3/5Y	7.39% 9.91%	ROIC	-759.83%	52W Low	0.95 8.39%	Perf 3Y	-86.69%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-54.09% -	Gross Margin	-828.89%	Volatility	4.61% 5.75%	Perf 5Y	-87.15%
Dividend TTM	-	EV/Sales	-91.55	EPS Y/Y TTM	48.96%	Oper. Margin	-28346.67%	ATR (14)	0.07	Perf 10Y	-98.09%
Dividend Ex-Date	-	Quick Ratio	5.89	Sales Y/Y TTM	11.11%	Profit Margin	-26078.89%	RSI (14)	41.50	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.89	EPS Q/Q	65.39%	SMA20	-6.46%	Beta	-0.01	Target Price	5.75
Payout	-	Debt/Eq	0.66	Sales Q/Q	-	SMA50	-12.92%	Rel Volume	0.66	Prev Close	1.02
Employees	25	LT Debt/Eq	0.34	Earnings	May 11	SMA200	-21.56%	Avg Volume	183.57K	Price	1.03
IPO	Jun 02, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.20% -	Trades		Volume	38,853	Change	1.16%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)